APA (7th ed.) Citation

Coussirou, J., Grenier, J., Mege, A., Arnaud, A., De Crozals, F., Bonnet, E., & Vazquez, L. (2026). Palbociclib in Combination with Endocrine Therapy in Patients with Metastatic Breast Cancer in a Real-World Population: Impact of Dose-Intensity, Dose Reductions and Cycle Delays on Efficacy. Current Oncology, 31(1), 51. https://doi.org/10.3390/curroncol33010051

Chicago Style (17th ed.) Citation

Coussirou, Julie, Julien Grenier, Alice Mege, Antoine Arnaud, Françoise De Crozals, Emmanuel Bonnet, and Léa Vazquez. "Palbociclib in Combination with Endocrine Therapy in Patients with Metastatic Breast Cancer in a Real-World Population: Impact of Dose-Intensity, Dose Reductions and Cycle Delays on Efficacy." Current Oncology 31, no. 1 (2026): 51. https://doi.org/10.3390/curroncol33010051.

MLA (9th ed.) Citation

Coussirou, Julie, et al. "Palbociclib in Combination with Endocrine Therapy in Patients with Metastatic Breast Cancer in a Real-World Population: Impact of Dose-Intensity, Dose Reductions and Cycle Delays on Efficacy." Current Oncology, vol. 31, no. 1, 2026, p. 51, https://doi.org/10.3390/curroncol33010051.